Buradasınız

UZUN DÖNEM HEMODİYALİZE BAĞLI ALÜMİNYUM İNTOKSİKASYONU VE NÖROTOKSİSİTESi GELİŞEN HASTALARDA Tc-99m HMPAO BEYİN SPECTİ

Tc-99m HMPAO BRAIN SPECT IN PATIENTS WITH ALUMINUM INTOXICATION AND NEUROTOXICITY OCCURING DUE TO LONG TERM HEMODIALYSIS

Journal Name:

Publication Year:

Abstract (2. Language): 
In this study, Tc-99m Hexamethylpropyleneamine oxime (HMPAO) brain perfusion single photon emission computed tomography (SPECT) was performed in patients with aluminum intoxication (AI) and expectable aluminum neurotoxicity (AN) occuring due to the treatment with long term hemodialysis. Because accumulation of aluminum in brain gray matter is the main cause of AN, we would like to determine if there is any detonation in brain perfusion and to localize the perfusion abnormalities in patients with AN and AI. Nine patients with AI, 2 with AN and 10 control subjects were included in the study. Tc-99m HMPAO brain SPECT were performed in all patients and control subjects. All patients were evaluated by neurological andpsycological examination and neuropsycological testing. Computerized tomography (CT) and Electroencephalography (EEG) were performed and serum aluminum levels were measured in all patients. Basal aluminium levels of the patients were above normal value. CT findings were normal in all patients. Pathologic and pathognomonic EEG was found in one patient with AN. In semiquantitative brain analysis, multiple regional decreased brain perfusion abnormalities were detected in 2 patients and multiple regional increased perfusion in 3 patients. Regional perfusion abnormalities were also observed in the other 5 patients but only in a few regions. Total 16 regions were hypo-perfused and 56 regions were hyper-perfused. We think that Tc-99m HMPAO brain perfusion SPECT study may help to explain the pathogenesis of some neuropsicological findings of AN.
Abstract (Original Language): 
Bu çalışmada uzun dönem hemodiyaliz tedavisine bağlı alüminyum intoksikasyonu (Al) ve nörotoksisitesi (AN) gelişen hastalara Tc-99m HMPAO beyin perfüzyon SPECT yapıldı.AN'nin ana sebebi beyin gri cevherinde Alüminyum birikmesi olduğundan böyle hastalarda meydana gelebilen beyin perfüzyon bozukluğunu saptamak ve lokalize etmek amaçlandı.Dokuz Al'HJki AN'li ve on sağlıklı kontrol çalışmaya alındı ve hepsine Tc-99m HMPAO beyin SPECT yapıldı.Bütün vakalara nörolojik, psikolojik muayene ve nöropsikolojik test uygulandı. Bilgisayarlı tomografi (BT) ve Elektroensefolografi (EEG) çekilip serum alüminyum seviyeleri ölçüldü. Bütün hastaların bazal Alüminyum seviyeleri normalin üstündeydi ve BT bulguları normaldi. AN'li bir hastada patolojik ve patagnomonik EEG tespit edildi. Semikantitatif beyin SPECT analizinde iki hastada çok sayıda bölgesel perfüzyon azalması,üç hastada çok sayıda bölgede perfüzyon artması saptandı.Diğer beş hastada ise sadece az sayıda bölgesel perfüzyon bozuklukları gözlendi.Toplam onaltı bölgede düşük perfüzyon, ellialtı bölgede ise yüksek perfüzyon tespit edildi. Bu bulgulara bağlı olarak Tc-99m beyin perfüzyon SPECT'in AN'de meydana gelen nöropsikolojik bozuklukların bir kısmım açıklamada yardımcı olacağını düşünmekteyiz-
FULL TEXT (PDF): 
100-105

REFERENCES

References: 

1. Alfrey AC. Phosphate, aluminum and other elements in chronic renal disorders. In: Schirier RW, Gottschalk CW. Diseases of the kidney, 1993, vol 3; 3156..
2. Lazarus JM, Hakim RM. Medical aspects of hemodialysis. In: Brenner BM, Rector FC. The Kidney. Phialdelphia W.B. Saunders Company , 1991,page 2256.
3. De Roo M, Mortelmans L, Devos P, et al: Clinical expeience with Tc-99m HMPAO high resolution SPECT of brain in patients with cerebrovascular accidents. Eur J NuclMed 1989; 15:9.
4. Costa DC. Single Photon Emission Tomography (SPECT) with Tc-99m hexamethylpropylenamineoxime (HMPAO) in research and clinical practice - a useful tool. Vase Med Rev 1990; 1 179.
5. Talairach J, Zilkha G,Toumoux P, et al: atlas d'anatomie sterotactique du telencephale. Masson: Paris: 1988.
6. Levi R, Wolf T, Fleminger G, Solomon B: Immuno-detection of aluminium and aluminium induced conformational changes in calmodulin-implications in
Alzheimer's disease. Mol Cell Biochem 1998: 189:41.
7. Belojevic G, Jakovljevic B: Aluminum and Alzheimer's
disease.B Srp Arh Celok Lek 1998; 126:283.
8. Fazekas G, Fazekas F, Schmidt R, et a1: Pattern of cerebral blood flow and cognition in patients undergoing chronic hemodialysis treatment. Nucl Med commun
1997; 17:603.
9. Gottlieb D, Mildwarf B, Rudinger D, et al: The regional cerebral blood flow in patients under chronic hemodialytic treatment. J Cereb Blood Flow Metab 7:
659, 1987.
10. Horina JH, Fazekas F, Niederkorn K et al: Cerebral hemodynamic changes following treatment with erythropoietin. Nephron 1991:58: 407.
11. Vorstrup S, Lass P, Waldemar G, et al: Increased cerebral blood flow in anemic patients on long-term hemodialytic
treatment. J Cereb Blood Flow Metab 1992; 12: 745.

Thank you for copying data from http://www.arastirmax.com